• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Protalix Biotherapeutics (NY: PLX )

    1.180 -0.040 (-3.28%)
    Streaming Delayed Price Updated: 11:11 AM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Protalix Biotherapeutics

    < Previous 1 2 3 Next >
    Stocks That Hit 52-Week Lows On Friday
    On Friday morning, 7 companies hit new 52-week lows. Key Facts: The largest company by market cap to set a new 52-week low was TAL Education (NYSE:TAL). The company... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Thursday
    On Thursday morning, 11 companies achieved new lows for the year. Intriguing Points: TAL Education (NYSE:TAL) was the biggest company on a market cap basis to set a new 52... 
    Via Benzinga
    Mid-Afternoon Market Update: Constellation Pharmaceuticals Surges Following Acquisition News; Protalix BioTherapeutics Shares Slide
    Toward the end of trading Wednesday, the Dow traded up 0.05% to 34,594.18 while the NASDAQ fell 0.16% to 13,715.08. The S&P also rose, gaining 0.02% to 4,202.76. The U.S. has... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Mid-Day Market Update: Crude Oil Rises 1%; iRhythm Technologies Shares Plunge
    `Midway through trading Wednesday, the Dow traded up 0.33% to 34,689.77 while the NASDAQ rose 0.16% to 13,758.43. The S&P also rose, gaining 0.30% to 4,214.55. The U.S. has... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
    Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
    Via Benzinga
    Exposures Product Safety
    66 Biggest Movers From Yesterday
    Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) surged 95.2% to close at $62.55 on Wednesday amid renewed interest from retail investors. AMC Entertainment shares jumped... 
    Via Benzinga
    Protalix Shares Hits 52-Week Low After Adverse Event Reported In Fabry Disease Trial With PRX-102
    Protalix BioTherapeutics Inc (NYSE: PLX) and Chiesi Farmaceutici S.p.A. have provided an update on the clinical development of pegunigalsidase alfa (PRX... 
    Via Benzinga
    40 Stocks Moving In Wednesday's Mid-Day Session
    Gainers BriaCell Therapeutics Corp. (NASDAQ: BCTX) shares jumped 147.3% to $7.86 after the company provided an update on the overall survival (OS) data on its previously... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    Before 10 a.m. ET on Wednesday, 8 companies hit new 52-week lows. Highlights: Dun & Bradstreet Hldgs (NYSE:DNB) was the biggest company by market cap to set a new 52-... 
    Via Benzinga
    Looking Into Protalix BioTherapeutics's Return On Capital Employed
    Protalix BioTherapeutics (AMEX:PLX) reported Q1 sales of $11.32 million. Earnings fell to a loss of $3.71 million, resulting in a 230.5% decrease from last quarter. In Q4,... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    Before 10 a.m. ET on Friday, 24 stocks hit new 52-week lows. Noteworthy Mentions: The largest company in terms of market cap to set a new 52-week low was Canadian... 
    Via Benzinga
    Earnings Scheduled For May 14, 2021
    Companies Reporting Before The Bell • Sogou (NYSE:SOGO) is projected to report earnings for its first quarter. • Sohu.com (NASDAQ:SOHU) is estimated to report... 
    Via Benzinga
    Earnings Preview for Protalix BioTherapeutics
    On Friday, May 14, Protalix BioTherapeutics (AMEX:PLX) will release its latest earnings report. Here is Benzinga's outlook for the company. Net Income, Earnings, And Earnings Per... 
    Via Benzinga
    The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... 
    Via Benzinga
    Exposures Product Safety
    Stocks That Hit 52-Week Lows On Tuesday
    Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... 
    Via Benzinga
    22 Stocks Moving in Monday's Pre-Market Session
    Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 58.3% to $78.90 in pre-market trading. Nicholas Jason Singer disclosed a 9.13% passive stake in Brooklyn... 
    Via Benzinga
    Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
    Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid... 
    Via Benzinga
    Mid-Afternoon Market Update: Dow Drops 90 Points; Fed Leaves Rates Unchanged
    Toward the end of trading Wednesday, the Dow traded down 0.26% to 33,894.93 while the NASDAQ fell 0.01% to 14,090.09. However, the S&P gained 0.13% to 4,192.05. The U.S. has... 
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    60 Biggest Movers From Yesterday
    Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares gained 75.6% to settle at $43.73 on Wednesday. The company recently said it paid $1 million towards acquisition of... 
    Via Benzinga
    Why Protalix BioTherapeutics Stock Is Plunging Today
    Investors did not like the company's latest regulatory update. 
    Via The Motley Fool
    Mid-Day Market Update: Crude Oil Rises 2%; Protalix BioTherapeutics Shares Plunge
    Midway through trading Wednesday, the Dow traded down 0.33% to 33,874.02 while the NASDAQ fell 0.07% to 14,079.66. The S&P also rose, gaining 0.15% to 4,193.17. The U.S. has... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    41 Stocks Moving In Wednesday's Mid-Day Session
    Gainers Aurora Mobile Limited (NASDAQ: JG) shares climbed 21.3% to $4.27 after Oppenheimer initiated coverage on the stock with an Outperform rating and a price target of $6 per... 
    Via Benzinga
    Mid-Morning Market Update: Markets Mixed; Alphabet Tops Q1 Expectations
    Following the market opening Wednesday, the Dow traded down 0.43% to 33,839.68 while the NASDAQ rose 0.10% to 14,104.41. The S&P also rose, gaining 0.19% to 4,194.68. The U.S... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... 
    Via Benzinga
    Exposures Product Safety
    25 Stocks Moving in Wednesday's Pre-Market Session
    Gainers RiceBran Technologies (NASDAQ: RIBT) rose 16.1% to $1.37 in pre-market trading after jumping around 27% on Tuesday. The company is scheduled to report Q1 earnings today.... 
    Via Benzinga
    Protalix Stock Falls After FDA Slaps CRL For PRX-102 Application In Fabry Disease
    Protalix BioTherapeutics Inc (NYSE: PLX) and Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici, have received a Complete Response... 
    Via Benzinga
    Exposures Product Safety
    The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ... 
    Via Benzinga
    Topics Intellectual Property
    Exposures Intellectual Property
    Understanding Protalix BioTherapeutics's Unusual Options Activity
    Protalix BioTherapeutics (AMEX:PLX) shares experienced unusual options activity on Monday. The stock price moved up to $6.25 following the option alert. Sentiment: BEARISH Option... 
    Via Benzinga
    The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
    Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... 
    Via Benzinga
    Exposures Product Safety
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.